Attila Tordai

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Top Venues

Expert review of hematology

Leukemia & lymphoma

The Journal of physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Randa Naffa, Luca Hegedűs, Tamás Hegedűs, Sarolta Tóth, Bela Papp, Attila Tordai, Ágnes Enyedi
Plasma membrane Ca 2+ pump isoform 4 function in cell migration and cancer metastasis. The Journal of physiology (2023)
Marcell Csanádi, Tamas Agh, Attila Tordai, Christoph Tapprich, Zoltán Vokó, Kostas Stamatopoulos
Secondary primary malignancies after treatment with chemo-immunotherapy in treatment-naïve patients with CLL: a systematic literature review. Expert review of hematology 15 (3) (2022)
Andrea Matusovits, Sándor Nagy, Klára Baróti-Tóth, János Nacsa, Mária Lázár, Imelda Marton, Hajnalka Andrikovics, Zoltan Vokó, Attila Tordai
National level adjustments to the challenges of the SARS-CoV2 pandemic on blood banking operations. Transfusion 61 (5) (2021)
Hajnalka Andrikovics, Zoltán Őrfi, Nóra Meggyesi, András Bors, Lívia Varga, Petra Kövy, Zsófia Vilimszky, Fanni Kolics, László Gopcsa, Péter Reményi, Attila Tordai
Current Trends in Applications of Circulatory Microchimerism Detection in Transplantation. International journal of molecular sciences 20 (18) (2019)
Attila Tordai, Andras Bors, Katalin Piroska Kiss, Katalin Balassa, Hajnalka Andrikovics, Arpad Batai, Aniko Szilvasi, Katalin Rajczy, Dora Inotai, Eva Torbagyi, Lilla Lengyel, Aniko Barta, Peter Remenyi, Tamas Masszi
Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning. PloS one 14 (6) (2019)
Marcell Csanádi, Tamas Agh, Attila Tordai, Thomas Webb, Dusha Jeyakumaran, Nishan Sengupta, Frida Schain, Jonas Mattsson
A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert review of hematology 12 (5) (2019)
Katalin Piroska Kiss, Gergely Varga, Gábor Mikala, Katalin Balassa, Andras Bors, Petra Kovy, Nora Meggyesi, Andras Kozma, Otto Csacsovszki, Peter Remenyi, Istvan Valyi-Nagy, Attila Tordai, Tamas Masszi, Hajnalka Andrikovics
The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma. Leukemia & lymphoma 59 (3) (2017)